1. Home
  2. Analysis
  3. Novantrone
  4. Dyspnea-exacerbated

Novantrone and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Novantrone (mitoxantrone hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cytarabine, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Novantrone. It is created by eHealthMe based on reports of 3,338 people who have side effects when taking Novantrone from the FDA, and is updated regularly.

What is Novantrone?

Novantrone has active ingredients of mitoxantrone hydrochloride. It is often used in multiple sclerosis. eHealthMe is studying from 3,349 Novantrone users. Check the latest studies of Novantrone.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,304 drugs and 1,659 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

On Jul, 31, 2026

3,338 people reported to have side effects when taking Novantrone.
Among them, 87 people (2.61%) have Dyspnea exacerbated.

Could Novantrone cause Dyspnea exacerbated?

Among these 87 people:

How long have people been on Novantrone when they have Dyspnea exacerbated? *

  • < 1 month: 43.9 %
  • 1 - 6 months: 21.95 %
  • 6 - 12 months: 7.32 %
  • 1 - 2 years: 7.32 %
  • 2 - 5 years: 19.51 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Dyspnea exacerbated when taking Novantrone? *

  • female: 60.47 %
  • male: 39.53 %

What is the age of people who have Dyspnea exacerbated when taking Novantrone? *

  • 0-1: 0.0 %
  • 2-9: 1.41 %
  • 10-19: 0.0 %
  • 20-29: 8.45 %
  • 30-39: 14.08 %
  • 40-49: 21.13 %
  • 50-59: 19.72 %
  • 60+: 35.21 %

What are other drugs people take besides Novantrone? *

  1. Baclofen: 10 people, 11.49%
  2. Cytarabine: 10 people, 11.49%
  3. Betaseron: 9 people, 10.34%
  4. Morphine: 8 people, 9.20%
  5. Rituxan: 8 people, 9.20%
  6. Rebif: 7 people, 8.05%
  7. Lasix: 6 people, 6.90%
  8. Etoposide: 6 people, 6.90%
  9. Cytoxan: 6 people, 6.90%
  10. Lortab: 6 people, 6.90%

What are other side effects people have besides Dyspnea exacerbated? *

  1. Ejection Fraction Decreased (systolic heart failure): 23 people, 26.44%
  2. Chest Pain: 16 people, 18.39%
  3. Fever: 16 people, 18.39%
  4. Weakness: 15 people, 17.24%
  5. Fatigue (feeling of tiredness): 15 people, 17.24%
  6. Malaise (a feeling of general discomfort or uneasiness): 13 people, 14.94%
  7. Pneumonia: 12 people, 13.79%
  8. Chills (felling of cold): 8 people, 9.20%
  9. Disease Progression: 8 people, 9.20%
  10. Influenza Like Illness: 8 people, 9.20%

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 9.20%
  2. Burkitt Lymphoma (cancer of the lymphatic system): 5 people, 5.75%
  3. Breast Cancer: 4 people, 4.60%
  4. Prostate Cancer: 3 people, 3.45%
  5. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 3.45%
  6. Headache (pain in head): 2 people, 2.30%
  7. Gait Disturbance: 1 person, 1.15%
  8. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 1.15%
  9. Anaemia (lack of blood): 1 person, 1.15%
  10. Breast Cancer Metastatic: 1 person, 1.15%

* Approximation only. Some reports may have incomplete information.

Do you take Novantrone and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novantrone:

Dyspnea exacerbated treatments and more:

How severe was Dyspnea exacerbated and when was it recovered:

Expand to all the drugs that have ingredients of mitoxantrone hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Novantrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Browse all the conditions that are associated with Dyspnea exacerbated:

How the study uses the data?

The study uses data from the FDA. It is based on mitoxantrone hydrochloride (the active ingredients of Novantrone) and Novantrone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.